EPI-506: Phase I/II started

Essa Pharma Inc. (TSX:EPI; NASDAQ:EPIX), Vancouver, B.C. Product: EPI-506 Business: Cancer Molecular target: Androgen receptor Description: Selective blocker of the N-terminus of the androgen recepto...